ARTICLE | Company News
Caprion, J&J deal
April 9, 2001 7:00 AM UTC
JNJ's Ortho-Clinical Diagnostics Inc. division (Raritan, N.J.) received an option to license Caprion's prion technologies, including monoclonal antibodies to detect new variant Creutzfeldt-Jacob's dis...